Title

Where Strategy and Ethics Converge: Pharmaceutical Industry Pricing Policy for Medicare Part D Beneficiaries

Document Type

Presentation

Publication/Presentation Date

10-2006

Academic Year

2006-2007

Publisher

13th Annual International Conference Promoting Business Ethics. Niagara Falls, New York. Oct. 2006

Abstract/Description

Description: Discussed the impact of the recently enacted Medicare Part D prescription drug benefit on prices of drugs used predominantly by the elderly. Compared the price effect that the original Medicare legislation had on hospital pricing structure. A conclusion suggests that overall social good is facilitated even though prices are expected to rise for pharmaceutical products.

This document is currently not available here.

Share

COinS